Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
about
Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadInfluenza virus neuraminidase (NA): a target for antivirals and vaccines.Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicityInfluenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Virus-vectored influenza virus vaccines.Fast vaccine design and development based on correlates of protection (COPs).Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesEfficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccineAntibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.Characteristics of vaccine failures in a randomized placebo-controlled trial of inactivated influenza vaccine in children.Influenza vaccines: from whole virus preparations to recombinant protein technology.Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness
P2860
Q26783897-624BF81D-4B74-4A45-A78F-58A4EA97865BQ30249879-97F67647-A388-4845-B9DA-5C1150FE1D2FQ30368005-E176A5CA-CF16-4765-BC60-99F66A754EEDQ30376724-91DF8AA5-2843-4850-8508-432582498803Q30382921-68C026A9-3B0F-4F75-A187-25D9CC608EAFQ30386612-E667147E-A0CC-4D06-8999-7E59FB8FBE0DQ33820732-EFD127AC-057C-418D-BA95-E08A7617446DQ34102268-6E81D8ED-64E3-40D3-AF29-DB50EF59E3BDQ34291098-A12443D5-3E55-49AD-836B-EC2834EE3B62Q34354440-9B559949-528B-4AED-BECE-CAAD9D2C4F53Q35214413-FF173311-768C-4885-A897-B76EFDD562AEQ35235777-66CAFC31-362A-4275-B94B-81F44CCE2C1EQ35408014-F9D9CB21-3401-40AE-8D1F-AC026AD52268Q35826733-4BDD6FA7-DA52-41E6-8F2B-0CBC9D8CF755Q35866636-BE58DE55-564D-428A-885B-A4229EE77D49Q37591325-C2A84237-55DB-424F-8978-CD00692695DFQ37625970-4B59527D-3E83-402A-AAE7-0E2E8319F3DBQ38160083-DDCE7362-1850-40E1-AE33-1ECE91F7CA7EQ41347626-55C98197-7B59-4724-8263-A4702CFD8D3AQ41933365-DD2F6250-CB89-4849-A596-0E978C1F627BQ47149344-C0FCEF21-A956-4C47-BF0E-C57556A427E6Q52609074-3C41D38F-5671-4B2D-A392-020C18DBA1BAQ57094018-CF7E0ED6-4F89-4563-BC57-951043AB43C3
P2860
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Randomized comparative study o ...... trivalent influenza vaccines.
@ast
Randomized comparative study o ...... trivalent influenza vaccines.
@en
type
label
Randomized comparative study o ...... trivalent influenza vaccines.
@ast
Randomized comparative study o ...... trivalent influenza vaccines.
@en
prefLabel
Randomized comparative study o ...... trivalent influenza vaccines.
@ast
Randomized comparative study o ...... trivalent influenza vaccines.
@en
P2093
P2860
P1433
P1476
Randomized comparative study o ...... trivalent influenza vaccines.
@en
P2093
Diane Niño
Janet Wells
John M Quarles
Nancy Arden
Robert B Couch
P2860
P304
P356
10.1016/J.VACCINE.2012.10.065
P407
P577
2012-10-26T00:00:00Z